Atlas Trials

T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant

Clinical trial NCT00986557 · UNKNOWN

Trial details

NCT number
NCT00986557
Sponsor
University Hospital Birmingham
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host DiseaseNonneoplastic Condition
Start date
2009-09-01
Primary completion
2013-08-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.